Cohere Health Adds Dr. Mark Leenay to Board to Advance Clinical AI Leadership and Health Plan Collaborations
BOSTON, Feb. 24, 2026 - Cohere Health® has appointed Dr. Mark Leenay to its board of directors. He brings deep leadership experience in medical cost management, clinical program development, and health plan operations, including senior roles at WellCare, Optum, and UnitedHealthcare.
This move strengthens Cohere Health's governance as it scales partnerships with innovative health plans and advances clinically led, agentic AI across payer-provider workflows. Dr. Leenay is a board-certified physician in family medicine and geriatrics with more than 20 years of clinical, operational, and executive experience.
Why this matters for executives
- Stronger governance for AI at scale: Board-level expertise in health plan operations increases the odds that AI programs drive measurable cost and quality outcomes rather than isolated pilots.
- Cost and utilization focus: Dr. Leenay's track record in payment programs and medical cost optimization supports enterprise initiatives across utilization management, care setting appropriateness, and benefit design execution.
- Payer-provider alignment: Cohere's platform targets decisions across prior authorization, policy, payment accuracy, and appeals-areas where speed and clarity translate to ROI and provider trust.
- Evidence of traction: The company reports 8x ROI and 94% provider satisfaction, indicating operational lift alongside clinical integrity.
"Dr. Leenay's appointment comes at a pivotal time as Cohere Health continues building momentum with our domain-specific, agentic AI and enterprise clinical intelligence platform," said Siva Namasivayam, CEO of Cohere Health. "He brings a rare perspective that combines physician-level clinical insights with executive health plan leadership-strategically aligned to our mission to help health plans transform decision-making throughout the care continuum."
"I believe clinically trained AI can make a meaningful difference in supporting patient care," Dr. Mark Leenay shared. "As a member of the board of directors, I look forward to supporting Cohere Health's mission by connecting health plans and providers to improve efficiency and address the challenges of rising healthcare costs."
Dr. Leenay's track record
- COO, ChenMed; CEO, InHealth MD Alliance; EVP and Chief Medical Officer, WellCare Health Plans; and a decade in executive leadership roles at UnitedHealth Group.
- Board-certified in family medicine and geriatrics; advisor to national and regional health plans on clinical and operational strategy.
- Doctor of Medicine from Thomas Jefferson University.
"Dr. Leenay's experience and insights as both a physician and health plan leader significantly strengthen Cohere Health's governance and strategic direction, supporting our efforts to advance payer-provider collaboration so patients receive the right care, in the right place, at the right time," said Dr. Gary Gottlieb, executive chair of Cohere Health.
Strategic implications for payers and providers
- Faster, clearer decisions: Streamlined determinations across prior authorization, policy, and appeals reduce friction and administrative spend.
- Medical cost performance: Clinically informed automation and guidance help target avoidable utilization, site-of-care optimization, and documentation quality.
- Scalable operating model: Enterprise clinical intelligence creates a common source of truth for plans and providers, improving consistency and auditability.
- Provider experience: Higher satisfaction increases adoption, which compounds value creation across lines of business.
What to watch next
- Expansion of agentic AI use cases beyond prior authorization into policy management, payment integrity, and appeals resolution.
- Deeper collaborations with national and regional plans, with outcome metrics such as time-to-yes, denial rates, avoidable admissions, and leakage reduction.
- Evidence of scale-more lines of business, broader specialty coverage, and tighter integration with provider workflows.
Cohere Health notes recent recognition, including TIME's World's Top HealthTech Companies 2025 list. See the list from TIME for broader industry context: TIME: World's Top HealthTech Companies.
For leaders shaping AI strategy and governance, explore practical playbooks and case studies in AI for Executives & Strategy.
Your membership also unlocks:
